VAERS reports by lot

Merck HPV lot 1602284: VAERS reports

38 VAERS reports list lot 1602284 as a Merck HPV vaccine, received between 2019-07-01 and 2022-09-12. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
38
Reports
11%
Marked serious
0
With a death outcome
15
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular1720%
Gastrointestinal1619%
Neurological1417%
General / Systemic (non-local)1012%
Autoimmune / Immune-mediated56%
Musculoskeletal56%
Dermatological (non-injection-site)56%
Injection-site / Local reaction56%
Psychiatric / Neuropsychiatric34%
Respiratory22%
Allergic / Anaphylactic11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Texas12
California3
New Jersey3
Florida2
New York2
Pennsylvania2
Nevada1
Indiana1
Montana1
Arkansas1
Puerto Rico1
Tennessee1

Reports by month received

2019-075
2019-086
2019-092
2019-101
2019-112
2019-121
2020-012
2020-022
2020-032
2020-061
2020-082
2021-014
2021-026
2021-101
2022-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.